Myoclonic Epilepsies, Progressive D020191

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Epilepsy » Epileptic Syndromes » Epilepsies, Myoclonic » Myoclonic Epilepsies, Progressive

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Epilepsy » Epilepsy, Generalized » Epilepsies, Myoclonic » Myoclonic Epilepsies, Progressive

Description

A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME.   MeSH

Hierarchy View

Subtype Terms (3)

Lafora Disease
1 experimental drug

Unverricht-Lundborg Syndrome
3 approved drugs


Phase 1 Indicated Drugs (1)


Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.